{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:57:11Z","timestamp":1793159831819,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042020kf1079"],"award-info":[{"award-number":["2042020kf1079"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["2018HX0003"],"award-info":[{"award-number":["2018HX0003"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270861"],"award-info":[{"award-number":["82270861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.eprac.2025.07.013","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:45:00Z","timestamp":1753202700000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Implications of Glucagon-like Peptide-1 Receptor Agonists on Thyroid Function and Thyroid Nodules: A Drug Target Mendelian Randomization and Cohort Study"],"prefix":"10.1016","volume":"32","author":[{"given":"Zhijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.07.013_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev-physiol-021113-170315","article-title":"Glucagon-Like peptide-1: glucose homeostasis and beyond","volume":"76","author":"Cho","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.eprac.2025.07.013_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eprac.2025.07.013_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-Like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"151","author":"Knudsen","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.eprac.2025.07.013_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.eprac.2025.07.013_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/dc17-1956","article-title":"No evidence of increase in calcitonin concentrations or development of C-cell malignancy in response to liraglutide for up to 5 Years in the LEADER trial","volume":"41","author":"Hegedus","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.07.013_bib6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/0192623315588999","article-title":"Effects of the GLP-1 receptor agonist dulaglutide on the structure of the exocrine pancreas of cynomolgus monkeys","volume":"43","author":"Vahle","year":"2015","journal-title":"Toxicologic Pathol"},{"key":"10.1016\/j.eprac.2025.07.013_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.eprac.2025.07.013_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040980","article-title":"Using mendelian randomization to improve the design of randomized trials","volume":"11","author":"Ference","year":"2021","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"10.1016\/j.eprac.2025.07.013_bib9","doi-asserted-by":"crossref","first-page":"1300-+","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"Vosa","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.eprac.2025.07.013_bib10","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"Classification and diagnosis of diabetes: Standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.07.013_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee","volume":"14","author":"Tessler","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.eprac.2025.07.013_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13156","article-title":"Uric acid level, gout and bone mineral density: a Mendelian randomization study","volume":"49","author":"Lee","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.eprac.2025.07.013_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.eprac.2025.07.013_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eprac.2025.07.013_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.eprac.2025.07.013_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4093\/dmj.2024.0105","article-title":"Use of glucagon-like peptide-1 receptor agonists does not increase the risk of cancer in patients with type 2 diabetes mellitus","volume":"49","author":"Kim","year":"2024","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.eprac.2025.07.013_bib17","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1097\/JS9.0000000000001514","article-title":"Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials","volume":"110","author":"Sun","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.eprac.2025.07.013_bib18","article-title":"Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study","volume":"385","author":"Pasternak","year":"2024","journal-title":"Bmj-British Med J"},{"key":"10.1016\/j.eprac.2025.07.013_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lfs.2014.09.004","article-title":"Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line","volume":"115","author":"Akiyama","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.eprac.2025.07.013_bib20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1210\/er.2008-0019","article-title":"Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling","volume":"29","author":"Gereben","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2025.07.013_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/jc.2011-2407","article-title":"Glucagon like peptide-1 receptor expression in the human thyroid gland","volume":"97","author":"Gier","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.013_bib22","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1210\/en.2014-1015","article-title":"Regulation and function of deiodinases during decidualization in female mice","volume":"155","author":"Deng","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.eprac.2025.07.013_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.653627","article-title":"Insulin-Like growth factor pathway and the thyroid","volume":"12","author":"Smith","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.013_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.651492","article-title":"Inhibition by thyroid hormones of cell migration activated by IGF-1 and MCP-1 in THP-1 monocytes: focus on signal transduction events proximal to integrin \u03b1v\u03b23","volume":"9","author":"Candelotti","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.eprac.2025.07.013_bib25","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/cancers13092230","article-title":"Diagnostic performances of the ACR-TIRADS system in thyroid nodules triage: a prospective single center study","volume":"13","author":"Leni","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.eprac.2025.07.013_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07435800.2018.1522641","article-title":"Effect of insulin on thyroid cell proliferation, tumor cell migration, and potentially related mechanisms","volume":"44","author":"Zhang","year":"2019","journal-title":"Endocr Res"},{"key":"10.1016\/j.eprac.2025.07.013_bib27","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s11739-021-02713-z","article-title":"Does insulin resistance trigger thyroid nodule?","volume":"16","author":"Demiral Sezer","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.eprac.2025.07.013_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000501895","article-title":"The effect of exenatide on thyroid-stimulating hormone and thyroid volume","volume":"8","author":"Sencar","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.eprac.2025.07.013_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4183\/aeb.2020.275","article-title":"Exenatide treatment reduces thyroid gland volume, but has no effect on the size of thyroid nodules","volume":"16","author":"Koseoglu","year":"2020","journal-title":"Acta Endocrinologica-Bucharest"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:51:27Z","timestamp":1777618287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1530891X25009711"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.013","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of Glucagon-like Peptide-1 Receptor Agonists on Thyroid Function and Thyroid Nodules: A Drug Target Mendelian Randomization and Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}